Login / Signup

Intravenous immunoglobulin G use in patients with chronic inflammatory demyelinating polyneuropathy: An uncommon cause of drug-induced discoid lupus erythematosus.

Tara JenningsSarah AhmedAbhishek AphaleJason LeeRodrigo Valdes-Rodriguez
Published in: The Australasian journal of dermatology (2019)
Drug-induced chronic cutaneous lupus erythematosus, or drug-induced discoid lupus erythematosus, is a rare cutaneous phenomenon. Various medications have been associated with drug-induced discoid lupus erythematosus including fluorouracile agents, especially tegafur and uraciltegafur, and TNF-α antagonists such as infliximab or etanercept. Recent literature has described a case series of six patients receiving IgG immunoglobulin for chronic inflammatory demyelinating polyneuropathy with subsequent presentations of discoid lupus erythematosus. We present a patient with chronic inflammatory demyelinating polyneuropathy who developed discoid lupus erythematosus secondary to IgG immunoglobulin.
Keyphrases
  • drug induced
  • liver injury
  • systemic lupus erythematosus
  • disease activity
  • rheumatoid arthritis
  • rheumatoid arthritis patients
  • oxidative stress
  • adverse drug
  • systematic review